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Mouse neonatal heart fragments or adult skin grafts were incubated 
either in an aqueous suspension of triamcinolone acetonide (TA) or in 
saline before grafting to isogeneic and allogeneic recipients. Almost 
invariably, TA incubated (40 or 10 mg/m1) heart fragment grafts failed 
to develop pulsatile or electrocardiographic activity. Likewise, TA 
incubated (40 mg/m1) skin grafts did not "take". In contrast, saline 
treated grafts (heart fragments and skin) did "take" and survive as 
expected. That is, isografts survived indefinitely, whereas 
allografts were rejected in normal first-set fashion. Apparently, 
pretreatment with TA significantly jeopardized the revascu1arization 
of both the i90- and a110grafted heart fragments and skin and resulted 
in consequent graft necrosis. 
v 
INTRODUCTION 
It is well known that the survival of skin allografts in various 
species can be prolonged by treating the recipient or the graft with 
corticosteroids following transplantation. This was first demon-
strated in 1951 by Billingham et ale (2) and by Morgan (20). Both 
groups administered cortisone acetate systemically to rabbits and 
found that skin allograft survival times were at least doubled. A 
lower dose applied directly to an intact graft also resulted in the 
doubling of allograft survival times (3). Woodruff and Llaurado (24) 
applied 9~ chloro- and 9a fluorocortisol and prednisone topically to 
rabbit skin allografts following transplantation. Their data likewise 
indicate significant prolongation of allograft survival. However, in 
these studies systemic doses of steroids either adversely affected 
graft vascularization and healing, or were toxic or even lethal to the 
recipient. Application of steroids directly to the graft reduced 
side effects to the host, but did not alleviate the effects to the 
graft itself. 
Recently, Klaue et ale (14-16) described a method for dramatic-
ally prolonging skin allograft survival with negligible side effects 
to the recipient. They demonstrated that the normal survival time for 
rabbit skin grafts could be more than tripled, when skin was trans-
planted to allogeneic recipients following its incubation in tri-
amcinolone acetonide (TA) (TA was the most effective corticosteroid 
of ten preparations tested). Most recently, Boss et a1. (5) reported 
that skin allograft survival times in mice were nearly doubled by 
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incubation of the grafts in TA prior to grafting. Klaue et al. (14-16) 
and Boss et al. (5) suggest that the TA pretreatment impedes both the 
afferent and efferent arcs of the immune response system, thereby 
prolonging survival by decreasing the onset and intensity of immuno-
logical reactions with the graft. In attempting to confirm their 
results, our emphasis has been to determine whether incubation in TA 
prior to grafting was deleterious to the graft itself, specifically 
regarding its ability to "take" and to function properly in vivo. 
Therefore, we grafted inbred mice with neonatal heart fragments which 
had been incubated in TA (6). This type of graft, which involves 
placing a fragment of newborn cardiac tissue subcutaneously in the 
recipient, provides a convenient, sensitive indicator of host immunity 
(9,11). Moreover, the occurrence of pulsation in these grafts is 
critically dependent on their prompt acquisition of a blood supply (7). 
Therefore, any consequent lack of expected function should signal 
possible damaging effects of TA incubation on the graft or its "take ll • 
In our experiments, we found that most of the neonatal heart grafts 
incubated with TA failed to develop the anticipated pulsatile activity. 
As these observations did not corroborate the previously published 
results with rabbit and mouse skin grafts (5,14-16), we conducted 
analogous experiments using mouse skin grafts incubated in TA. 
MATERIALS AND METHODS 
Three to four month old male mice of the highly inbred C3Hf and 
CBA strains from our colony were used as recipients. The C3Hf strain 
was the donor for both neonatal heart tissue and adult skin grafts. 
The C3Hf and CBA strains are histocompatible at the H-2 locus, but 
differ at enough non-H-2 loci to yield first-set skin allograft 
rejection within three weeks after grafting, with a median survival 
time of approximately thirteen days. 
The technique described by Fulmer et ale (6) was used to place a 
randomly dissected, one-quarter heart equivalent fragment into a 
pocket prepared in the dorsum of the left ear pinna. The only modifi-
cations to this technique were: 1) that a l3-gauge trochar was used 
to inject the graft into the prepared pocket; and 2) that a Sanborn 
ECG machine with 30-gauge needles as electrodes was used for recording 
graft electrical activity. 
The plan of the experiments was similar for both neonatal heart 
and adult skin grafts. Heart fragments, obtained from neonatal C3Hf 
donors (with disregard to sex) within 48 hours post-partum, were 
placed in either a suspension of TA (Squibb, Kenalog~ 40 Injection 
[TA 40 mg/ml] or Kenalog~lO Injection [TA 10 mg/ml]) or a 0.9% NaCl 
solution (McGraJV Normal Saline). As described by Klaue et ale 
(14-16), grafts were soaked in 2 ml suspensions of TA at a concentra-
tion of 40 or 10 mg/ml or in an equal volume of saline solution for 
60 min. at room temperature, then grafted immediately. The incubation 
containers were kept on a laboratory shaker at low speed in order to 
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keep the TA in suspension. Following incubation, grafts incubated in 
TA were rinsed in saline. Half of the fragments in each group were 
transplanted to CBA recipients as allografts, and half were grafted to 
C3Hf recipients as isografts. By concurrently comparing the tltakes" 
and survival of treated and non-treated iso- and allografts, we were 
able to observe if: 1) TA were deleterious to the activity of the 
graft in vivo; and 2) could prolong the survival time of the 
allografts. At least four C3Hf fragments from both TA and saline 
incubated groups were fixed in pH 7.0 buffered 10% formalin immedi-
ately following incubation. At 10 days post-grafting, additional 
histological samples were taken by removing ears containing intact 
TA or saline treated isografts, trimming these to include only the 
implanted fragment surrounded by a minimum of host tissue and fixing 
them in formalin. 
Daily from day 6 post-grafting, the hosts were anesthetized with 
ether and heart graft pulsation was observed visually with a 2.5-4X 
Optivisor holding the ear before a high intensity lamp to illuminate 
the graft. When pulsatile activity was not clearly visible, electrical 
activity was monitored. As even untreated isografts sometimes develop 
irregular or transient pulsatile activity (6,13) a "take" was defined 
as any graft which pulsated for at least two consecutive days. The 
endpoint of rejection was defined as the day of the last recorded 
pulsatile activity, if it were followed by five consecutive days of 
negative ECG recordings. 
We grafted mouse skin by the technique described by Billingham (1), 
using circular 15 mm diameter, belly skin grafts from adult male donor& 
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These were incubated and grafted to recipients as previously described. 
At least four grafts from both TA and saline groups were fixed in 
formalin immediately following incubation. Eight days after grafting, 
the dressings were removed and a careful gross examination of each 
graft was conducted. At least 4 intact TA and saline treated skin 
isografts were pulled from their recipients and fixed in formalin. A 
skin graft "take" was defined on the basis of graft color and observ-
able thickness. Furthermore, it was determined if the graft was 
firmly attached to its bed and if bleeding occurred when an edge of 
the graft was lifted up with forceps. For example, isografts incubated 
in saline appear pinkish in color and of comparable thickness to host 
skin at primary inspection. Any attempt to dislodge a normal isograft 
from its bed at 8 days requires tearing it from its position with 
consequent bleeding. 
RESULTS 
A. Heart fragment grafts 
The proportions of heart fragment iso- and allograft "takes" are 
presented in Table 1. In numbers 1-5, each experiment was conducted 
using concurrent TA and saline-treated, iso- and a110grafted heart 
fragments. These results show that 42/45 (93%) of the iso- and 
allografts incubated in TA did not "take". In fact, the only TA 
t~eated grafts that developed pulsatile activity were the 3 allografts 
in experiment 1. Using the Mann-Whitney U test (23), we compared the 
survival times of these 3 allografts with the 5 corresponding allo-
grafts which had been incubated in saline, and found no significant 
difference between them. 36/47 (77%) of the iso- and allografts 
incubated in saline did "take". As incubation may have affected the 
heart fragment graft and its "take", we compared saline-incubated with 
freshly transplanted isografts (Experiments 6-9). Clearly, there are 
no significant differences between the proportions of saline incubated 
and fresh grafts that did "take". Moreover, the overall 70-73% "takes" 
of isografts in experiments 1-9 are obviously consistent. Less than 
100% "takes" of fresh heart fragment isografts have been quite common 
(6,13). Nevertheless, once pulsation was established, these isografts 
remained active throughout the duration of the experiment. 
Collectively, the results in Table 1 show an obvious difference 
between the proportions of TA and control groups of both iso- and 
allografts that "take". Although there was some variation among 
experiments, those saline incubated iso- and allografts that pulsated 
• 
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appeared ruddy and were generally accompanied by some h_orrhage around 
the heart fragment in the ear pilllla, with subsequmt development of 
cOll8picuous vasculature. The TA treated fragments generally did not 
pulsate and appeared pale, with the exception of the three pulsatile 
allografts mentioned previously. Microscopically, TA and saliDa 
incubated heart fragments appeared equally viable just prior to graft-
ing. However, on day 10 post-grafting, TA and saline treated isografts 
differed strikingly in regard to viability and blood supply. TA 
treated heart fragments in the ear were necrotic and lacked a blood 
supply (Figure 1). By contrast, saline treated fragments were well 
vascularized and appeared viable (Figure 2). 
B. Skin grafts 
As seen in Table 2, the results of incubating skill grafts in TA 
or saline for 60 minutes were similar to the results obtained with 
hear~ fragment grafts. None of the TA treated isografts nor allografts 
was scored as a "take". However, all saline treated grafts did "take". 
Grafts incubated ill TA appeared unusually pale and thin at primary 
inspection. Also, these grafts were easily peeled off their beds 
without bleeding. Microscopically, as with heart fragment grafts, 
TA and saline treated skin did not differ prior to grafting. However, 
on day 8 post-grafting, TA treated isografts were necrotic and lacked 
a blood supply (Figure 3). Saline treated isografts were again viable 
and vascularized (Figure 4). 
DISCUSSION 
We have found that incubation in TA almost invariably precluded 
the development of pulsatile activity in iso- and allografted mouse 
heart fragments. As observed by Fulmer et a1. in mice (6) and 
Greenblatt et ale in hamsters (7), variations in the patterns of 
developing vasculature which do not provide optimal initial blood 
supply often influence the onset of pulsations and the survival of 
heart fragment grafts. Indeed, they suggest that the extent of 
pulsatile activity in this type of heart graft is highly correlated 
with the extent of vascularity. Accordingly, we conclude that a likely 
reason for the failure of heart fragment grafts to "take" was that 
these grafts failed to revascularize and obtain an adequate blood 
supply. Certainly, the anti-proliferative action of TA could account 
for such an effect on vascularization. This conclusion is substan-
tiated by the differences of appearance observed when intact TA and 
saline treated heart fragment grafts were compared grossly. Further-
more, the vessels of TA treated grafts were devoid of erythrocytes when 
viewed microscopically, whereas the vessels of saline treated grafts 
were engorged with red blood cells. It was not conclusive from our 
observations why the grafts subsequently became necrotic. However, two 
likely possibilities are TA mediated, ischemic necrosis and/or direct 
TA damage to the cells of the graft. We draw no conclusion regarding 
the possible prolongation of allograft survival times by TA treatment, 
as there were insufficient numbers involved for adequate statistical 
analysis. The incidence of saline incubated isografts that "took" 
was similar to that of freshly grafted isografts. 
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As with heart fragment grafts, iso- and allografted skin pre-
treated with TA did not "take". Again, we conclude that TA treatment 
retarded the revascularization of skin iso- and allografts, and 
resulted in consequent graft necrosis. The gross effects observed on 
TA treated mouse skin grafts are similar to those observed by others 
on rabbit skin grsfts treated with cortisone and with TA (2,3,16). 
Klaue et al. (16) reported that their TA treated rabbit skin allografts 
appeared pale and " ••• were somewhat atrophic and less well vascu-
larized with delayed epithelization of the gap between host and skin". 
When our 8-day post-operative isografts were observed microscopically, 
the epithelium of the skin treated with TA was necrotic, with no 
evidence of proliferation. By comparison, the isografts treated with 
saline showed a moderate hyperplasia of the graft epithelium. Klaue 
et ale (16) did observe " ••• atrophy of the epidermis. " in TA 
treated allografts, but no necrosis, microscopically. As Klaue et ale 
(14-16) and Boss et ale (5) sutured full-thickness skin grafts into 
position on their hosts, the full extent of ischemia may not have been 
apparent. The grafts may have been temporarily preserved because the 
sutures kept them in sufficient contact with the graft bed to keep 
them moist and soft until they eventually "sloughed off" •. In contrast, 
the edges of our nonsutured, "free" TA treated grafts were usually 
turned up and hard, and were held to the bed by a crusty, scab-like 
material. As the grafts were lightly scraped with forceps, they 
became loose, and were effortlessly "peeled off" the graft bed. Of 
course, it might be suggested that if we had left the dressing in 
place for several more days, a better union of graft and host might 
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have occurred. However, this was unlikely, since our TA treated grafts 
were necrotic. Regardless, our results with both heart fragment and 
skin grafts in mice suggest that powerful synthetic corticosteroids, 
such as triamcinolone acetonide, may have limited or no applicability 
for prolonging the survival of naturally vascularizing grafts because 
of their anti-proliferative activity or other effects. 
The 40 and 10 mg/ml concentrations of TA used for the incubation 
of heart fragments and skin were chosen because Klaue et ale reported 
that these were most effective for prolonging skin allograft survival 
times in rabbits. Boss et ale (5) have since prolonged reciprocal 
BALB/c and C57BL/6 mouse skin allografts by incubating with TA 
(40 mg/ml) prior to grafting. We used a different strain combination, 
C3Hf to CBA. However, it is unlikely that this TA dosing would have 
had a specific or preferential toxic effect on C3H tissue as compared 
to those of BALB/c or C57BL/6. 
It is also possible that species differences might account to some 
extent, at least, for our results in mice, in contrast to those in 
rabbits (14-16). According to Medawar and Sparrow (19), it takes more 
than six times the daily dose of cortisone to double the survival time 
of skin allografts in mice as it does in rabbits. Indeed, the graft 
prolongation achieved following TA incubation in mice (5) was not as 
striking as that achieved in rabbits (16). Consequently, it is 
possible that damaging effects of TA on iso- and allografted mouse 
heart and skin may have superseded any immunosuppressive effects. 
There are reports in the literature that incubating skin allo-
grafts in thalidomide (8), urethane (4), mucopolysaccharides (18), 
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nucleic acids (17), gluteraldehyde and poly(L-lysine) (22), and 
chlorphensin (21) reduces their immunogenicity or prolongs their 
survival. However, not enough attention has been given to the possible 
deleterious effects of such pretreatments. For example, Schechter (22) 
incubated mouse skin in gluteraldehyde and found that its survival 
when allografted was tripled compared to non-treated controls. However, 
When isografted, the skin also "sloughed off" in a similar manner to 
the allografts, which were thought to have had undergone rejection. 
1m and Simmons (10), in repeating Schechter's experiments, found that 
the skin allografts, treated in vitro with gluteraldehyde in concen-
trations which prolonged survival, were actually histologically fixed 
and non-viable. 
Clearly, there is little significance to any prolonged allograft 
survival achieved by pretreatment with agents such as TA, if the 
treatment jeopardizes the function or viability of the grafts. Con-
sequently, these agents must be evaluated for possible deleterious 
effects with autografts or isografts, whose long-term survival and 
function can be studied in the absence of host resistance, before any 


















Neonatal heart fragment grafts: the effect of incubation with TA on the proportion of "takes"a. 
Isografts (C3H-+C3H) Allografts (C3H~CBA) 
TA Saline TA Saline 






0/7 0/13 16/23 
(70%) 
Saline 


























a See Materials and Methods. 
t""'I 
..... 
Table 2. Adult skin grafts: the effect of incubation with TA on the proportion of "takes"a. 
Isografts (C3H~C3H) Allografts (C3H~CBA) Experiment 
No. TA (40 mg/mlL_ Saline TA (40 mg/tnl) Sal:l.ne 
1 0/5 5/5 0/5 5/5 
2 0/7 7/7 0/5 7/7 
Total 0/12 12/12 0/10 12/12 
a See Materials and Methods. 
LEGENDS 
Fig. 1: Graft of heart tissue, subsequent to TA (40 mg/ml) incubation, 
10 days after transplantation to syngeneic mouse ear. Graft 
is necrotic and lacks vascularization. Note cartilage of 
mouse ear on right. H & E, X 415. 
Fig. 2: Same as Fig. 1, but subsequent to saline incubation. Graft 
appears viable and is well vascularized. 
Fig. 3: Skin graft, subsequent to TA incubation~ 8 days after trans-
plantation to syngeneic mouse. The graft is necrotic and 
lacks vascularization. 
Fig. 4: Same as Fig. 3, but subsequent to saline incubation. Graft 
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Daily aurvival curv.. (pulaatile activity) of 3 TA and 4 .aline 
incubated h.art fragment allografts (from Experiment 1; a •• 
Tabl. 1.). 
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